Display options
Share it on

J Sports Sci Med. 2015 May 08;14(2):322-32. eCollection 2015 Jun.

Effects of time-release caffeine containing supplement on metabolic rate, glycerol concentration and performance.

Journal of sports science & medicine

Adam M Gonzalez, Jay R Hoffman, Adam J Wells, Gerald T Mangine, Jeremy R Townsend, Adam R Jajtner, Ran Wang, Amelia A Miramonti, Gabriel J Pruna, Michael B LaMonica, Jonathan D Bohner, Mattan W Hoffman, Leonardo P Oliveira, David H Fukuda, Maren S Fragala, Jeffrey R Stout

Affiliations

  1. Institute of Exercise Physiology and Wellness, Sport and Exercise Science, University of Central Florida , Orlando, FL USA.

PMID: 25983581 PMCID: PMC4424461

Abstract

This study compared caffeine pharmacokinetics, glycerol concentrations, metabolic rate, and performance measures following ingestion of a time-release caffeine containing supplement (TR-CAF) versus a regular caffeine capsule (CAF) and a placebo (PL). Following a double-blind, placebo-controlled, randomized, cross-over design, ten males (25.9 ± 3.2 y) who regularly consume caffeine ingested capsules containing either TR-CAF, CAF, or PL. Blood draws and performance measures occurred at every hour over an 8-hour period. Plasma caffeine concentrations were significantly greater (p < 0.05) in CAF compared to TR-CAF during hours 2-5 and significantly greater (p = 0.042) in TR-CAF compared to CAF at hour 8. There were no significant differences between trials in glycerol concentrations (p = 0.86) or metabolic measures (p = 0.17-0.91). Physical reaction time was significantly improved for CAF at hour 5 (p=0.01) compared to PL. Average upper body reaction time was significantly improved for CAF and TR-CAF during hours 1-4 (p = 0.04 and p = 0.01, respectively) and over the 8-hour period (p = 0.04 and p = 0.001, respectively) compared to PL. Average upper body reaction time was also significantly improved for TR-CAF compared to PL during hours 5-8 (p = 0.004). TR-CAF and CAF showed distinct pharmacokinetics yielding modest effects on reaction time, yet did not alter glycerol concentration, metabolic measures, or other performance measures. Key pointsTime-release caffeine and regular caffeine showed distinct pharmacokinetics over an 8-hour period following ingestion.Time-release caffeine and regular caffeine yielded modest effects on reaction time over an 8-hour period following ingestion.Time-release caffeine and regular caffeine did not alter glycerol concentration, metabolic measures, or other performance measures over an 8-hour period following ingestion.

Keywords: Caffeine bioavailability; energy; multiple object tracking; pharmacokinetics; reaction time; sustained release caffeine

References

  1. Appetite. 1994 Feb;22(1):39-55 - PubMed
  2. Psychopharmacology (Berl). 1993;112(2-3):359-65 - PubMed
  3. J Nutr Sci Vitaminol (Tokyo). 2001 Apr;47(2):139-46 - PubMed
  4. Psychopharmacology (Berl). 2001 Nov;158(3):322-8 - PubMed
  5. Clin Pharmacol Ther. 1982 Jul;32(1):98-106 - PubMed
  6. Am J Clin Nutr. 1989 Jan;49(1):44-50 - PubMed
  7. Percept Mot Skills. 2003 Feb;96(1):67-78 - PubMed
  8. Int J Pharm. 2002 Mar 2;234(1-2):159-67 - PubMed
  9. J Sleep Res. 2001 Dec;10(4):265-76 - PubMed
  10. Am J Clin Nutr. 1990 May;51(5):759-67 - PubMed
  11. Psychopharmacology (Berl). 2004 Oct;176(1):1-29 - PubMed
  12. Ann Nutr Metab. 1995;39(3):135-42 - PubMed
  13. Med Sci Sports. 1978 Fall;10(3):155-8 - PubMed
  14. Psychopharmacology (Berl). 1987;92(3):308-12 - PubMed
  15. J Strength Cond Res. 2014 Aug;28(8):2079-87 - PubMed
  16. J Appl Physiol (1985). 2004 Jan;96(1):50-8 - PubMed
  17. Psychiatry Res. 1991 Mar;36(3):291-8 - PubMed
  18. J Alzheimers Dis. 2010;20 Suppl 1:S85-94 - PubMed
  19. Am J Clin Nutr. 1980 May;33(5):989-97 - PubMed
  20. Aviat Space Environ Med. 1996 Sep;67(9):859-62 - PubMed
  21. Int J Neurosci. 2009;119(8):1239-58 - PubMed
  22. Physiol Behav. 2011 Oct 24;104(5):816-22 - PubMed
  23. Aviat Space Environ Med. 2005 Jul;76(7):647-54 - PubMed
  24. Hum Psychopharmacol. 2000 Apr;15(3):153-170 - PubMed
  25. Eur J Clin Pharmacol. 1996;51(3-4):319-25 - PubMed
  26. Psychopharmacology (Berl). 2002 Nov;164(3):250-61 - PubMed
  27. Eur J Clin Pharmacol. 1981;21(1):45-52 - PubMed
  28. Psychopharmacology (Berl). 2000 Oct;152(2):167-73 - PubMed
  29. Pharmacol Rev. 1999 Mar;51(1):83-133 - PubMed
  30. Nutr Rev. 2001 Apr;59(4):91-102 - PubMed
  31. Am J Clin Nutr. 1981 Oct;34(10):2291-4 - PubMed
  32. Hum Psychopharmacol. 2005 Jan;20(1):47-53 - PubMed
  33. J Sports Sci Med. 2014 Jan 20;13(1):145-50 - PubMed
  34. Neuropsychobiology. 2005;51(1):16-27 - PubMed
  35. Int J Neurosci. 2009;119(7):975-94 - PubMed
  36. Hum Psychopharmacol. 2005 Aug;20(6):441-5 - PubMed
  37. J Sleep Res. 2001 Sep;10(3):203-9 - PubMed
  38. J Int Soc Sports Nutr. 2010 Jan 27;7(1):5 - PubMed
  39. Sleep. 2000 Aug 1;23(5):651-61 - PubMed
  40. Food Chem Toxicol. 1996 Jan;34(1):119-29 - PubMed
  41. Crit Rev Food Sci Nutr. 2005;45(7-8):535-62 - PubMed

Publication Types